CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.
about
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingMechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanomaDifferential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation.Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.Inhibitory costimulation and anti-tumor immunity.Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapyDendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.Modulation of CTLA-4 and GITR for cancer immunotherapy.Immune regulatory antibodies: are they the next advance?Vitiligo, reactive oxygen species and T-cells.Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.New approaches for the immunotherapy of acute myeloid leukemia.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells.Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses.Immune and molecular correlates in melanoma treated with immune checkpoint blockade.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
P2860
Q27334215-2954FFEE-7D8C-4B3C-B216-FA65DE0468E4Q30433217-0038BC29-3BBB-4CD8-9D82-E70C25E28ACCQ33653210-3D3E3E63-32E2-4A55-85F7-8E80897EE61CQ34353266-14BFF06B-9A96-4AF6-B63B-EE0A13A92189Q34824109-F3A9BF94-9DD1-4763-8796-6A5B4FA2ED57Q35594089-738260B7-6FE9-4C95-B406-5B2F61B0CFEFQ35753931-2C2F09D9-D0DF-49B6-B808-6D7AA0BC023AQ36016292-01C67298-D218-4278-ABD6-A470030F4A99Q36286133-19A35C26-D1A1-4AF1-B5A3-E5794F97A799Q36498243-FAA66D88-8C6B-4428-A214-D904826E4A40Q36935749-A17A0466-C27A-4326-9365-687B944BCF05Q37394755-987D4C78-0311-4E74-8910-1807DF229F41Q37766483-69E33AD9-BD42-4571-BA17-EE546135C709Q37778691-9508E9ED-8BA2-45C0-B104-E3A30EEE894DQ37801388-55C3586B-56B5-40D2-BAFF-DDDD0F14FE27Q38093572-F23395DD-A171-4DC5-9AE6-042FB376AB83Q38482206-4459EF1C-77EB-45C6-BBEB-0610E76060E8Q38636569-3D1D0CEA-72EF-478A-A64E-01F96DA7BE74Q38880404-1DFCAB82-3840-4A3E-B2C4-DA8A8CD01837Q39143599-6A98DA96-7099-42A3-80C4-2B601C3DC6AEQ39262779-D87ACA6B-7368-441C-A1C6-DE4906A5393EQ39329603-158443BB-47B4-4995-93CD-BC6B8B64072EQ39419931-AF01E9A2-B5A1-4B83-B4BF-620426ABE21A
P2860
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@ast
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@en
type
label
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@ast
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@en
prefLabel
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@ast
CTLA-4 dysregulation of self/t ...... tion is CD4+ T-cell dependent.
@en
P2093
P2860
P1433
P1476
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
@en
P2093
Anju Ranganathan
David M Heimann
Deborah R Surman
Luca Gattinoni
Marc R Theoret
Paul A Antony
Steven A Rosenberg
P2860
P304
P356
10.1182/BLOOD-2006-07-034066
P407
P577
2006-08-01T00:00:00Z